Liposome: composition, characterisation, preparation, and recent innovation in clinical applications
- PMID: 30239255
- DOI: 10.1080/1061186X.2018.1527337
Liposome: composition, characterisation, preparation, and recent innovation in clinical applications
Abstract
In the last decades, pharmaceutical interested researches aimed to develop novel and innovative drug delivery techniques in the medical and pharmaceutical fields. Recently, phospholipid vesicles (Liposomes) are the most known versatile assemblies in the drug delivery systems. The discovery of liposomes arises from self-forming enclosed phospholipid bilayer upon coming in contact with the aqueous solution. Liposomes are uni or multilamellar vesicles consisting of phospholipids produced naturally or synthetically, which are readily non-toxic, biodegradable, and are readily produced on a large scale. Various phospholipids, for instance, soybean, egg yolk, synthetic, and hydrogenated phosphatidylcholine consider the most popular types used in different kinds of formulations. This review summarises liposomes composition, characterisation, methods of preparation, and their applications in different medical fields including cancer therapy, vaccine, ocular delivery, wound healing, and some dermatological applications.
Keywords: Liposomes; applications; cancer; drug delivery; phospholipids; wound healing.
Similar articles
-
Liposome-based delivery system for vaccine candidates: constructing an effective formulation.Nanomedicine (Lond). 2012 Dec;7(12):1877-93. doi: 10.2217/nnm.12.157. Nanomedicine (Lond). 2012. PMID: 23249332 Review.
-
Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems.Crit Rev Biotechnol. 1999;19(4):317-57. doi: 10.1080/0738-859991229170. Crit Rev Biotechnol. 1999. PMID: 10723627 Review.
-
Trends and developments in liposome drug delivery systems.J Pharm Sci. 2001 Jun;90(6):667-80. doi: 10.1002/jps.1023. J Pharm Sci. 2001. PMID: 11357170
-
Liposomal drug delivery systems: an update review.Curr Drug Deliv. 2007 Oct;4(4):297-305. doi: 10.2174/156720107782151269. Curr Drug Deliv. 2007. PMID: 17979650 Review.
-
Liposomes as biocompatible and smart delivery systems - the current state.Adv Colloid Interface Sci. 2022 Nov;309:102757. doi: 10.1016/j.cis.2022.102757. Epub 2022 Aug 19. Adv Colloid Interface Sci. 2022. PMID: 36152374 Review.
Cited by
-
Finasteride-loaded nano-lipidic carriers for follicular drug delivery: preformulation screening and Box-Behnken experimental design for optimization of variables.Heliyon. 2022 Aug 15;8(8):e10175. doi: 10.1016/j.heliyon.2022.e10175. eCollection 2022 Aug. Heliyon. 2022. PMID: 36042733 Free PMC article.
-
Advancing Medicine with Lipid-Based Nanosystems-The Successful Case of Liposomes.Biomedicines. 2023 Feb 2;11(2):435. doi: 10.3390/biomedicines11020435. Biomedicines. 2023. PMID: 36830971 Free PMC article. Review.
-
Safety, Stability, and Therapeutic Efficacy of Long-Circulating TQ-Incorporated Liposomes: Implication in the Treatment of Lung Cancer.Pharmaceutics. 2022 Jan 9;14(1):153. doi: 10.3390/pharmaceutics14010153. Pharmaceutics. 2022. PMID: 35057049 Free PMC article.
-
Nanoform of Phospholipid Composition: Investigation of the Morphological Features by Atomic Force Microscopy.Int J Mol Sci. 2023 Oct 19;24(20):15338. doi: 10.3390/ijms242015338. Int J Mol Sci. 2023. PMID: 37895017 Free PMC article.
-
Therapeutic Potential of Nanocarrier Mediated Delivery of Peptides for Wound Healing: Current Status, Challenges and Future Prospective.AAPS PharmSciTech. 2024 May 10;25(5):108. doi: 10.1208/s12249-024-02827-5. AAPS PharmSciTech. 2024. PMID: 38730090 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources